Private insurance claim lines for sexually transmitted diseases (STDs) rose 76% nationally from 2007 to 2018, according to a new study of STDs from FAIR Health, a national, independent nonprofit organization dedicated to bringing transparency to healthcare costs and health insurance information. The study results, which are being released in the form of an infographic, are based on analysis of data from FAIR Health’s comprehensive repository of over 30 billion private healthcare claim records—the largest in the country.
According to the Centers for Disease Control and Prevention (CDC), combined cases of syphilis, gonorrhea and chlamydia, the three most commonly reported STDs, reached an all-time high in the United States in 2018. FAIR Health’s findings shed new light on this growing public health issue.
Among the results of the FAIR Health study:
Claim lines with STD diagnoses, as a percentage of all medical claim lines, increased nationally 76 percent from 2007 to 2018, but the increase was even greater in rural areas—98%, compared to 77% in urban areas (FIGURE 1).
Source: FAIR Health
The 4 STD diagnoses whose associated claim lines had the greatest percent increase from 2007 to 2018 as a percentage of all medical claim lines were:
The age groups most associated with STDs in 2018 varied by the specific disease. The age groups that accounted for the largest share of claim lines were:
From 2007 to 2018, claim lines with gonorrhea diagnoses as a percentage of all medical claim lines by gender increased 326% in males compared to 47% in females (FIGURE 2).
In individuals over 60 years of age, hepatitis B was the STD that showed the highest percent increase in claim lines from 2007 to 2018, and claim lines for hepatitis B increased more in the over 60 cohort (149%) than in any other age group.
The age groups with the greatest increase in claim lines from 2007 to 2018 were:
It is central to FAIR Health’s mission to use our vast repository of claims data to research public health concerns and support such research by others. We hope this information brings greater clarity to the growing problem of STDs.
For the FAIR Health infographic on STDs, click here.
Learning From Past Innovations to Advance Ventilation Use in Respiratory Conditions
May 21st 2024In a keynote presentation at ATS 2024, Hannah Wunsch, MD, MSc, of Weill Cornell Medicine, delved into how the history of breathing support dating back to the 1700s has set the stage for ventilation advances still being made today.
Read More
Frameworks for Advancing Health Equity: Urban Health Outreach
May 9th 2024In the series debut episode of "Frameworks for Advancing Health Equity," Mary Sligh, CRNP, and Chelsea Chappars, of Allegheny Health Network, explain how the Urban Health Outreach program aims to improve health equity for individuals experiencing homelessness.
Listen
Surgery, Chemotherapy Considered Protective Survival Factors in Patients With OC, Liver Metastases
May 21st 2024Surgery and chemotherapy significantly improved both overall survival (OS) and cancer-specific survival (CSS) in patients with liver metastases originating from ovarian cancer (OC), who generally face a poor prognosis with a 5-year survival rate of less than 30%.
Read More
ATS 2024 Data Support Triple Therapy FF/UMEC/VI as Preferred Option for COPD
May 21st 2024New data reveal that starting furoate/umeclidinium/vilanterol (FF/UMEC/VI) without delay not only significantly reduces exacerbations and health care costs but also enhances adherence and persistence for patients with chronic obstructive pulmonary disease (COPD) compared with other therapies.
Read More